The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application notesELISA: Use at an assay dependent dilution. For coating order antibody without BSA.
RIA: Use at an assay dependent dilution.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
RelevanceMPA (also known as depo provera) is a highly potent progestational steroid that has been used worldwide as a contraceptive. There has been a concern about the possibility of an increased risk of breast cancer associated with its use. On the other hand, MPA when employed at high doses (>0.5 - 1.0g / day i.m.) can produce objective remission with improved survival in about 30% of postmenopausal women with advanced breast cancer resistant to cytotoxic drugs and endocrine therapies. Early results suggest that the response rate can be increased in patients with estrogen and / or progesterone positive receptors.
Medroxyprogesterone acetate antibody
References for Anti-Medroxy progesterone Acetate antibody [MP01 (same as 1F5)] (ab44966)
has not yet been referenced specifically in any publications.
Publishing research using ab44966? Please let us know so that we can cite the reference in this datasheet.
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"